Circ Cardiovasc Qual Outcomes 2017 Jun;10(6)
From the National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease (Z.Z., H.Z., X.Y., C.R., Y.Z., S.H.), and Department of Cardiovascular Surgery (Z.Z., H.Z., X.Y., C.R., S.H.), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; Department of Health Care Policy, Harvard Medical School and the Department of Biostatistics, Boston, MA (S.-L.N.); Harvard T.H. Chan School of Public Health, Boston, MA (Y.W., S.-L.N.); Center for Outcomes Research and Evaluation, Yale New Haven Health, CT (Y.W., H.M.K.); Section of Cardiovascular Medicine, Department of Internal Medicine (H.M.K.), and Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine (H.M.K.), Yale School of Medicine, New Haven, CT; and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.).
: Coronary artery disease is prevalent in China, with concomitant increases in the volume of coronary artery bypass grafting (CABG). The present study aims to compare CABG-related outcomes between China and the United States among large teaching and urban hospitals.Methods And Results
: Observational analysis of patients aged ≥18 years, discharged from acute-care, large teaching and urban hospitals in China and the United States after hospitalization for an isolated CABG surgery. Read More